At the American Association of Clinical Endocrinology 2025 Annual Meeting, Jaime Almandoz, MD, MBA, FTOS, discussed the importance of continuing medical treatment for patients with obesity following...
A study presented at the American Association of Clinical Endocrinology (AACE) Annual Meeting in Orlando, FL examines skin conditions and foot ulcers in patients in Nepal with endocrine disorders and...
A post hoc analysis of the SURMOUNT-1 trial reveals that cardiometabolic improvements achieved after 176 weeks of tirzepatide may diminish significantly within 17 weeks of treatment cessation, particularly...
According to a study presented at the American Association of Clinical Endocrinology Annual Meeting 2025, patients with type 2 diabetes face significantly lower bone mineral density and an increased risk of...
Despite unchanged treatment modalities for over 75 years, contemporary management of Graves’ disease increasingly centers on preserving thyroid function, with methimazole emerging as the preferred...
